Ono Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPHLY research report →
About the company
Ono Pharmaceutical Co. , Ltd. , along with its subsidiaries, operates globally, engaging in the research, development, procurement, and commercialization of pharmaceutical products and diagnostic reagents.
- CEO
- Gyo Sagara
- IPO
- 2012
- Employees
- 3,853
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $7.02B
- P/E
- 16.29
- P/S
- 2.20
- P/B
- 1.34
- EV/EBITDA
- 7.62
- Div Yield
- 3.31%
- Gross Margin
- 72.52%
- Op Margin
- 20.03%
- Net Margin
- 13.53%
- ROE
- 8.54%
- ROIC
- 7.95%
- Revenue
- $546.89B · 12.33%
- Net Income
- $73.97B · 47.81%
- EPS
- $52.73 · 48.46%
- Op Income
- $109.57B
- FCF YoY
- 86.23%
- 52W High
- $5.75
- 52W Low
- $3.41
- 50D MA
- $4.86
- 200D MA
- $4.69
- Beta
- 0.14
- Avg Volume
- 37.84K
Get TickerSpark's AI analysis on OPHLY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OPHLY coverage
Recent articles, reports, and earnings notes.
No research on OPHLY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OPHLY report →Similar companies
Peers in the same neighborhood.